According to DHH, drug overdose deaths are now the number one cause of accidental death in the United States.
LSMS is honored to have our members Dr. John Noles and Dr. Sarah Hamauei present the curriculum on Opioid Prescribing: Safe Practice Changing Lives, Clinicians Making a Difference.
- This is a FREE event
- FREE PARKING
- CME and CNE offered
- Light Hors d'Oeuvres will be served
- Registration is limited
- Registration begins at 5:00
Who Should Attend? (suggested but not limited to)
- Healthcare professionals such as nurses and other clinicians
- Public Health professionals
- Health Plans
On July 9, 2012, the Food and Drug Administration (FDA) approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioid medications. The Collaborative on REMS Education (CO*RE), a multidisciplinary collaboration of 10 Partners and three cooperating organizations, have designed a core curriculum based on needs assessment, practice gaps, clinical competencies, learner self-assessment with shared tools, resources, and outcomes to meet the requirements of the FDA REMS Blueprint.
- FDA Blueprint
- Patient Selection and assessment of risk associated with opioid use for long term management of chronic pain
- Initiation and modification of ER/LA prescriptions, ongoing monitoring, and counseling for patients
- Legal, regulatory, safety perspectives
Presented by the Louisiana State Medical Society, a cooperating member of the Collaborative on REMS Education (CO*RE) interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.
RPC Commercial Support Disclosure Statement:
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.
*This activity has been planned and implemented in accordance with requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) through the joint providership of LAMMICO and LSMS. LAMMICO is accredited by the ACCME to provide continuing medical education for physicians. LAMMICO is also accredited as a provider of continuing nursing education by the ANCC’s Commission on Accreditation. LAMMICO designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™ or 2 continuing nursing education credits. Physicians and nurses should claim only the credit commensurate with the extent of their participation in this activity.